AUSTIN, Texas– Autonomize AI, a rising force in artificial intelligence for healthcare, has raised $28 million in a Series A funding round to scale its agentic AI platform aimed at transforming operational workflows across the healthcare and life sciences sectors. The latest round brings the company’s total funding to $32 million.
The investment was led by Valtruis, The Cigna Group Ventures, and Tau Ventures, with participation from existing backers including Asset Management Ventures, ATX Venture Partners, and Capital Factory. The funding will be used to expand Autonomize AI’s Agentic AI Orchestration platform, which helps reduce administrative burdens in clinical settings and enables healthcare professionals to focus more on patient care.
CEO and co-founder Ganesh Padmanabhan emphasized the urgency of change in the healthcare system. “The current infrastructure no longer aligns with how care is delivered today. Patients and clinicians are too often hindered by delays and inefficiencies,” he said. “Automation alone won’t fix healthcare—but human-centered, accountable AI can. This funding allows us to expand a platform that augments human expertise while tackling some of the most frustrating operational challenges.”
Unlike generic generative AI systems, Autonomize AI’s technology is tailored specifically for regulated healthcare environments. Its platform employs multiple pre-trained AI agents that function as coordinated “Copilots” to manage complex tasks such as utilization management, benefits verification, care coordination, and chart reviews. These agents are designed to understand real-world workflows and deliver results at enterprise scale.
The company’s platform is already being used by Fortune 100 healthcare organizations, where it has led to measurable efficiency gains. Autonomize AI reports that its system currently saves over 36,000 clinical hours per month, automates the creation of more than 100,000 care plans, and accelerates decision-making in prior authorizations and claims by up to 50%.
Investors say the company’s traction stems from its understanding of healthcare’s unique demands. “Healthcare is ready for AI—but not the kind built in a vacuum,” said Mike Spadafore, Managing Director at Valtruis. “Autonomize AI stands out because it delivers measurable results by integrating deeply with how care is actually delivered and paid for.”
The company also emphasizes transparency and regulatory compliance, incorporating human-in-the-loop oversight and explainability into every aspect of its AI system.
Craig Cimini, Head of The Cigna Group Ventures, said Autonomize AI’s approach aligns with broader efforts to modernize healthcare without displacing its workforce. “Their vision for augmenting—not replacing—healthcare workers is critical,” Cimini said. “We see tremendous potential in their ability to responsibly scale innovation while keeping patients and providers at the center.”
Founded in 2022 by Padmanabhan and Kris Nair, Autonomize AI has rapidly gained traction in both healthcare and life sciences sectors. The company is already demonstrating how purpose-built AI can address administrative bottlenecks and make the healthcare experience more efficient, accessible, and patient-focused.
